Sono-hepatic-arteriography (Sono-HA) in the assessment of hepatocellular carcinoma in patients undergoing transcatheter arterial chemoembolization (TACE)

Ultraschall in der Medizin

Volumn 31, Issue 3, 2010, Pages 270-275

  Schacherer, D ^a   Girlich, C ^a   Zorger, N ^a   Wiest, R ^a   Schoelmerich, J ^a   Feuerbach, S ^a   Jung, E M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Chemoembolization; Tumor; Ultrasound

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; COMPARATIVE STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; ELECTROCOAGULATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; VASCULARIZATION;

AGED; ANGIOGRAPHY; ANGIOGRAPHY, DIGITAL SUBTRACTION; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; CONTRAST MEDIA; ELECTROCOAGULATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PALLIATIVE CARE; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 77953109873     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0029-1245242     Document Type: Article

References (34)

1. Bosch F X., Ribes J, Diaz M et al. Primary liver cancer, worldwide incidence and trends. Gastroenterology 2004 127 5-16
2. Forner A, Hessheimer A J., Real I M. et al. Treatment of hepatocellular carcinoma. Critical Rev Oncol Hematol 2006 60 89-98
3. Schmidt J, Strotzer M, Fraunhofer S et al. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg 2000 24 43-47
4. Strotzer M, Gmeinwieser J, Schmidt J et al. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997 38 986-992
5. Conlon R, Jacobs M, Dasgupta D et al. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003 16 211-216
6. Mazzaferro V, Battiston C, Perrone S et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004 240 900-909
7. Rode A, Bancel B, Douek P et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001 25 327-336
8. Libbrecht L, Bielen D, Verslype C et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transp 2002 8 749-761
9. Ledinghen V de, Laharie D, Lecesne R et al. Detection of nodules in liver cirrhosis: spiral computed tomograpy or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002 14 159-165
10. Kim Y K., Kwak H S., Kim C S. et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006 238 531-541
11. Kato H, Kanematsu M, Kondo H et al. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging 2004 19 76-81
12. Barthia B, Ward J, Guthrie J A. et al. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol 2003 180 577-584
13. Kim S R., Ando K, Mita K et al. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Oncology 2007 72 58-66
14. Tsurusaki M, Sugimoto K, Fujii M et al. Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma. Clin Radiol 2007 62 1189-1197
15. Larson A C., Wang D, Atassi B et al. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma: feasibility of initial clinical translation. Radiology 2008 246 964-971
16. Peterson M S., Baron R L. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001 5 123-144
17. Liu W C., Lim J H., Park C K. et al. Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol 2003 13 1693-1698
18. Rickes S, Schulze S, Neye H et al. Improved diagnosing of small hepatocellular carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis. Eur J Gastroenterol Hepatol 2003 15 893-900
19. Tanaka S, Ioka T, Oshikawa O et al. Dynamic sonography of hepatic tumors. Am J Roentgenol 2001 177 799-805
20. Gaiani S, Celli N, Piscaglia F et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004 41 421-426
21. Quaida E, Calliada F, Bertolotto M et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004 232 420-430
22. Jung E M., Clevert D A., Schreyer A G. et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007 13 6356-6364
23. Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) update 2008. Ultraschall in Med 2008 29 28-44
24. Herbay A von, Haeussinger D, Gregor M et al. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contras agents SonoVue (BR 1) and Levovist (SHU 508A) comparison of SonoVue and Levovist in HCC. Ultraschall in Med 2007 28 168-175
25. Rickes S, Ocran K, Schulze S et al. Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis. Ultraschall in Med 2002 23 83-90
26. Kumada T, Nakano S, Takeda I et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. Journal of hepatology 1999 30 125-130
27. Bruix J, Sherman M. AASLD Practice Guideline: Management of hepatocellular carcinoma. Hepatology 2005 42 1208-1236
28. Cormier J N., Thomas K T., Chari R S. et al. Management of hepatocellular carcinoma. J Gastrointest Surg 2006 10 761-780
29. Llado L, Virgili J, Figueras J et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoemboliztion. Cancer 2000 88 50-57
30. Yamasaki T, Matsukawa T, Arakawa A et al. US-guided liver biopsy: predicting the effect of interventional treatment of hepatocellular carcinoma. Radiology 1995 196 799-804
31. Ito K, Honjo K, Fujita T et al. Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology. J Comput Assist Tomogr 1995 19 198-203
32. Zhao J G., Feng G S., Kong X Q. et al. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World J Gastroenterol 2004 10 1152-1156
33. Kono Y, Lucidarme O, Choi S H. et al. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2007 18 57-65
34. Numata K, Morimoto M, Ogura T et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008 27 395-406